Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Equity Average (2024 - 2025)

Historic Equity Average for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $298.2 million.

  • Beta Bionics' Equity Average rose 23251.38% to $298.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $298.2 million, marking a year-over-year increase of 23251.38%. This contributed to the annual value of -$224.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Equity Average is $298.2 million, which was up 23251.38% from $307.7 million recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' Equity Average peaked at $307.7 million during Q2 2025, and registered a low of -$237.1 million during Q4 2024.